第 1 到 6 筆結果,共 6 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation | Fu, Yu-Hsuan; DA-LIANG OU ; Yang, Yi-Ru; Su, Kuan-Wei; Chen, Chien-Yuan ; HWEI-FANG TIEN ; Shen, Che-Kun James; Shen, Che-Kun James; Chien, Hsiung-Fei; LIANG-IN LIN | Cancer Gene Therapy | 2 | 1 | |
2 | 2022 | Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias | Su, Kuan-Wei; DA-LIANG OU ; Fu, Yu-Hsuan; HWEI-FANG TIEN ; HSIN-AN HOU ; LIANG-IN LIN | Cancer Gene Therapy | 3 | 2 | |
3 | 2019 | Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib | Ko, Ya-Chen; CHUNG-YI HU ; Liu, Zheng-Hau; HWEI-FANG TIEN ; DA-LIANG OU ; Chien, Hsiung-Fei; LIANG-IN LIN | International journal of molecular sciences | 6 | 5 | |
4 | 2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen, Chien-Yuan ; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 25 | 26 | |
5 | 2015 | MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine | Lu J.-W.; Lin Y.-M.; Lai Y.-L.; Chen, Chien-Yuan ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Medical Oncology | 20 | 19 | |
6 | 2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 39 | 37 |